Loading...

Odonate Therapeutics, Inc.

ODTCPNK
Healthcare
Biotechnology
$22005.00
$5005.00(29.44%)
U.S. Market opens in 3h 21m

Odonate Therapeutics, Inc. (ODTC) Stock Competitors & Peer Comparison

See (ODTC) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ODTC$22,005.00+29.44%8B1.07$20,580.00N/A
NONOF$41.50+0.80%185.9B11.59$3.61+4.52%
CSLLY$23.04-2.17%89.5B15.00$1.54+3.10%
UCBJF$275.59-3.40%52.5B29.29$9.41+0.55%
UCBJY$131.96-5.34%50.5B28.25$4.70+0.57%
ARGNF$781.00+0.00%48.3B39.85$19.60N/A
CMXHF$90.49-4.88%43.9B14.67$6.17+3.14%
WXIBF$4.70+0.00%19.4B27.65$0.17N/A
IVBXF$11.08+7.68%19.1B158.25$0.07N/A
WXXWY$8.56+1.18%17.7B25.21$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ODTC vs NONOF Comparison April 2026

ODTC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ODTC stands at 8B. In comparison, NONOF has a market cap of 185.9B. Regarding current trading prices, ODTC is priced at $22,005.00, while NONOF trades at $41.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ODTC currently has a P/E ratio of 1.07, whereas NONOF's P/E ratio is 11.59. In terms of profitability, ODTC's ROE is +0.07%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, ODTC is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ODTC.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions